ContraFect Announces Fourth Quarter and Full Year 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
ContraFect (CFRX) PT Trimmed to $7 at Maxim Group as Results Awaited
March 15, 2016 10:22 AM EDTMaxim Group analyst Jason Kolbert maintained a Buy rating but trimmed his price target on ContraFect Corp. (NASDAQ: CFRX) to $7.00 (from $8.00) following quarterly results. The company spent $7.5M and ended with $33M in cash, or a year's worth of capital. The next... More
ContraFect (CFRX) Misses Q4 EPS by 5c
March 15, 2016 8:55 AM EDTContraFect (NASDAQ: CFRX) reported Q4 EPS of ($0.28), $0.05 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on ContraFect (CFRX) click here.
... More